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Sin Nombre orthohantavirus (SNV), a negative-sense, single-stranded
RNA virus that is carried and transmitted by the North American deer mouse
Peromyscus maniculatus, can cause infection in humans through inhalation of aerosolized excreta from infected rodents. This infection can lead to hantavirus cardiopulmonary syndrome (HCPS), which has an ;36% case-fatality rate. We used reverse
transcriptase quantitative PCR (RT-qPCR) to conﬁrm SNV infection in a patient and
identiﬁed SNV in lung tissues in wild-caught rodents from potential sites of exposure. Using viral whole-genome sequencing (WGS), we identiﬁed the likely site of
transmission and discovered SNV in multiple rodent species not previously known to
carry the virus. Here, we report, for the ﬁrst time, the use of SNV WGS to pinpoint a
likely site of human infection and identify SNV simultaneously in multiple rodent
species in an area of known host-to-human transmission. These results will impact
epidemiology and infection control for hantaviruses by tracing zoonotic transmission
and investigating possible novel host reservoirs.
ABSTRACT

IMPORTANCE Orthohantaviruses cause severe disease in humans and can be lethal in
up to 40% of cases. Sin Nombre orthohantavirus (SNV) is the main cause of hantavirus disease in North America. In this study, we sequenced SNV from an infected
patient and wild-caught rodents to trace the location of infection. We also discovered SNV in rodent species not previously known to carry SNV. These studies demonstrate for the ﬁrst time the use of virus sequencing to trace the transmission of
SNV and describe infection in novel rodent species.
KEYWORDS Sin Nombre, hantavirus, reservoir, sequencing, transmission

O

rthohantavirus is a genus of negative-sense, single-stranded RNA viruses from the
order Bunyavirales and the family Hantaviridae (1). Orthohantavirus genomes are trisegmented and encode four proteins. The small (S) segment encodes the nucleoprotein
(N) and the nonstructural protein NSs, the medium (M) segment encodes a polyprotein
that is a precursor for glycoproteins Gn and Gc (known previously as G1 and G2), and the
large (L) segment encodes the viral RNA-dependent RNA polymerase (2). The New World
orthohantavirus Sin Nombre orthohantavirus (SNV) is the primary etiological agent of hantavirus cardiopulmonary syndrome (HCPS) in North America. The primary host reservoir for
SNV is thought to be Peromyscus maniculatus (North American deer mouse). Other
Peromyscus species have been reported to be seropositive for SNV and could serve as
potential secondary reservoirs (3–5). Previous studies have also shown antibody reactivity
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with multiple small mammals throughout the Southwest, including species of the genera
Microtus, Onychomys, Reithrodontomys, and Spermophilus (4, 6–9). However, such ﬁndings
were largely based on host antibodies, which may cross-react with endemic nonpathogenic hantaviruses (10). Furthermore, sequencing of large portions of SNV genomes in
rodents other than P. maniculatus has not been reported.
HCPS was ﬁrst documented in North America during the 1993 outbreak in the Four
Corners region (New Mexico, Arizona, Utah, and Colorado) of the United States, with additional previously suspected cases reported retrospectively (11, 12). Symptoms of HCPS
begin 1 to 7 weeks (median of ;3 weeks) after exposure and consist of fever, headache,
and myalgia, with severe cases progressing to cardiopulmonary syndrome. The overall
case-fatality rate is approximately 36% but can be higher in individual outbreaks (13).
Peripheral blood smear criteria consistent with SNV infection include hemoconcentration,
left shift in the white blood cell count (WBC), thrombocytopenia, .10% circulating immunoblasts, and the absence of toxic granules in neutrophils (14).
There are currently no approved therapeutics or vaccines for SNV, making it important to understand the distribution of this virus in associated host reservoirs to enhance
risk reduction strategies. Some states have been identiﬁed as being disproportionately
burdened with HCPS cases, potentially linked to favorable breeding conditions of rodent
hosts and increased circulation of the virus (13). New Mexico has reported the highest
number of HCPS cases (15), and the question of whether P. maniculatus is the only host
that can carry and spread SNV or whether additional reservoirs exist has not been thoroughly explored.
To date, direct tracing of SNV transmission by sequencing viral genomes of infected
rodents and then correlating these data with patient infection has not been examined.
Studies have suggested that the sizes of the host populations are dependent on a bottom-up, trophic cascade in which the prevalence of hantavirus transmission is primarily
based on aspects of the biology of the primary host (P. maniculatus), such as food availability and population dynamics, which are heavily inﬂuenced by periodic climatic
events (e.g., the El Niño Southern Oscillation) (16). However, if multiple rodent species
serve as SNV hosts, then the dynamics of viral circulation and increased zoonotic transmission to humans could be more complex. Therefore, SNV needs to be explored as an
emerging/reemerging disease in the context of a greater understanding of the distribution of host reservoirs to help develop more accurate risk models for the prevention
of SNV outbreaks (17).
In this study, we investigated the source of human SNV infection from a patient in
New Mexico. We used reverse transcriptase quantitative PCR (RT-qPCR) to conﬁrm infection in both the patient and wild-caught rodents near two sites of potential zoonotic
transmission. We then sequenced the genomes of SNV from the potential hosts and
compared them to the genome sequence of SNV from the patient to investigate the
likely site of patient infection. In addition, we conducted genome sequencing of SNV
PCR-positive specimens obtained from rodents other than P. maniculatus. Altogether,
this is the ﬁrst study to use genomic epidemiology to trace the origin of an SNV infection
and identify SNV in multiple rodent species at the site of a human infection.
RESULTS AND DISCUSSION
SNV conﬁrmation and disease progression. In 2020, a 57-year-old Caucasian male
from northern New Mexico without known relevant medical history presented to a
local clinic with symptoms of fever, myalgias, and headache for 1 to 2 days. Symptoms
progressed to nausea, diarrhea, and hypoxia, with laboratory tests showing thrombocytopenia but normal white blood cell (WBC) count and hematocrit (Hct). Amid the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, the patient
had been practicing social distancing, with no travel or encounters with sick individuals. The patient was tested and found to be negative for SARS-CoV-2 RNA, suggesting
that he was suffering from another respiratory syndrome. The patient was transferred
to the University of New Mexico Hospital and placed on a high-ﬂow nasal cannula, and
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FIG 1 SNV RT-qPCR detection in clinical samples and wild-caught rodents. (A) Singleplex SNV-speciﬁc ampliﬁcation of patient samples using cycle
threshold (CT) values plotted along with negative- and positive-control patient plasma and SNV-infected Vero E6 cells (Puriﬁed SNV). (B) Copies per milliliter
were calculated using an SNV N gene plasmid standard curve with an R2 value of 0.998. (C) Lung tissues from wild-caught rodents were plotted using CT
values, with each species labeled a color according to the key, along with controls from infected or uninfected rodents and puriﬁed SNV (gray). Limits of
detection (LoD) for plots were determined using a no-template control (NTC).

additional laboratory testing was performed. Interstitial markings were observed on
subsequent chest X rays. The peripheral blood smear met 4 of 5 criteria (all except
hemoconcentration) for a presumptive diagnosis of HCPS in the cardiopulmonary
stage. The patient developed acute kidney injury, and sheaths were placed for potential extracorporeal membrane oxygenation (ECMO), but he did not progress to require
that therapy. Serology for SNV infection was positive for IgM, but IgG was equivocal.
He was discharged on oxygen after 10 days of hospitalization. RT-qPCR was used to conﬁrm the diagnosis by the detection of SNV RNA. Using SNV-speciﬁc TaqMan primers and
probe (18), patient serum, whole blood, and plasma were tested for SNV, and all three
samples were positive (Fig. 1A). A standard curve with an R2 value of 0.998 of known
concentrations of a plasmid containing the N gene for SNV was used to calculate copies
per milliliter (Fig. 1B). Copy numbers of SNV genomes in the patient’s samples were comparable to previously published ﬁndings from other infected individuals (19).
Assessment of potential sites of rodent-to-human SNV transmission. The
patient lived on a ranch in northern New Mexico and had exposure to chickens, dogs,
December 2021 Volume 95 Issue 23 e01534-21
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TABLE 1 Summary of rodents captured from both potential sites of exposure in northern New Mexico and tested for SNVa
Species
Peromyscus maniculatus

No. of rodents
captured (%)
41 (59)

No. of rodents at
location
32, site 1
9, site 2

No. of M/F rodents (%
SNV positive)
16 (44)/16 (38)
4 (50)/5 (40)

No. of rodents with SNVpositive lung tissue (%)
13 (41)
4 (44)

Peromyscus boylii

4 (6)

0, site 1
4, site 2

1 (100)/3 (33)

2 (50)

5 (20)/4 (50)

3 (33)

Mus musculus

9 (13)

9, site 1
0, site 2

Neotoma mexicana

4 (6)

0, site 1
4, site 2

0 (0)/4 (0)

5, site 1
6, site 2

3 (33)/2 (50)
2 (0)/4 (50)

Tamias minimus

11 (16)

Total

69 (100)

aM/F

2 (40)
2 (33)

26 (38)

represents the number (percentage) of SNV-positive rodents of each sex (male/female).

cats, and cattle. Activities prior to infection included cleaning out sheds on two properties 2 to 3 weeks prior to the onset of symptoms, where the patient noted rodent
infestation that included mouse droppings. Two weeks after the patient’s diagnosis,
we conducted ﬁeld trapping of rodents from two potential sites of exposure, site 1 (TR)
and site 2 (T2), which were in rural areas separated by approximately 15 miles.
Trapping locations consisted of several outdoor buildings that were found near woodpiles and vegetation that showed signs of rodent infestation and activity. Rodent nests
were found at both sites, inside sheds and on the outskirts of the buildings. We
hypothesized site 1 to be the source of transmission as this was located near the primary residence; however, both sites were trapped over a 2-night period. A total of 69
rodents were obtained, and tissues were collected and stored until screening. To identify SNV within potential host reservoirs, we used RT-qPCR to detect the SNV S segment
in RNA isolated from the lung tissues of all 69 rodents.
High SNV positivity rate in wild-caught rodents and novel potential rodent
reservoirs. We found that 38% (26/69) of trapped rodents were positive for SNV RNA
overall, with 39% of site 1 rodents being positive and 35% of rodents being positive at
site 2 (Fig. 1C and Table 1). The identity of all SNV-positive rodents was conﬁrmed by
cytochrome b Sanger sequencing of lung tissue and analysis by BLAST (data not
shown). In total, we trapped 46 rodents at site 1 and 23 at site 2, with most rodents
being P. maniculatus (59%). In addition, we found rodents of another species of
Peromyscus, Peromyscus boylii (pinyon mouse), which were trapped only at site 2. Mus
musculus (common house mouse) was caught only at site 1. Neotoma mexicana
(Mexican woodrat) rodents were primarily found at site 2 and associated with middens,
or nests, found on the outside of some of the buildings. We trapped several Tamias
minimus (least chipmunk) rodents at both sites; these animals were very active both
inside and outside some of the structures suspected for exposure. Surprisingly, we
detected SNV not only in P. maniculatus but also in multiple samples from P. boylii and
M. musculus (Table 1). Unexpectedly, we also found that of the 11 captured T. minimus
rodents, 4 were positive for SNV. We did not ﬁnd any apparent signs of illness in the
SNV-positive rodents, suggesting that, like previous reports for P. maniculatus, other
SNV-infected rodents may be largely asymptomatic as well. Furthermore, we found
that of captured P. maniculatus rodents, 9 of 20 (45%) males tested positive for SNV,
while 8 of 21 (38%) females were positive; previous publications have shown a higher
SNV antibody prevalence in male than in female P. maniculatus rodents (20–23).
Sequencing of SNV from clinical and rodent samples. To examine the genetic relationships between the clinical isolate and the viruses found in the rodent samples, we
December 2021 Volume 95 Issue 23 e01534-21
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FIG 2 Phylogenetic analysis of captured P. maniculatus and patient samples suggests transmission at the residential site (site 1). A
maximum likelihood tree was generated based on concatenated S, M, and L segments. Bootstrap support is indicated. Both sites
were within a 15-mile radius and are indicated as residential site (TR [site 1]) (blue) or second site (T2 [site 2]) (orange). Patient
plasma and whole blood were sequenced and are shown (teal). The tree was rooted to the Prospect Hill reference sequence.
Additional hantavirus reference sequences were obtained through the NCBI. SNV from infected Vero E6 cells (SNV VERO) was
used as a positive sequencing control. The bar represents the number of substitutions per site.

sequenced the genomes of SNVs from the patient’s whole blood and plasma, 8 rodent
samples (4 from each site), and a cell culture-passaged control (SN77734) reported previously (18). We developed a multiplex PCR-tiling scheme to sequence the three segments
of SNV based on protocols utilized for Zika virus (24). To achieve higher genome coverage,
some gaps were ﬁlled using Sanger sequencing. Viral genome coverage across the samples ranged between 47% and 99% completeness when mapped against the SNV reference genome NMH10 (GenBank accession numbers NC_005215, NC_005216, and NC
_005217), which was the ﬁrst sequence for a human SNV infection (25).
We placed these genomes into a phylogenetic framework via alignment and compared individual rodent sample genomes with the patient sample genomes (Fig. 2). Our
analysis shows that all SNV genomes sequenced in this study clustered together in the
phylogeny. The patient SNV genomes formed a tight cluster with genomes found in two
rodents trapped at site 1 (Fig. 2): P. maniculatus TR008 was trapped near a greenhouse,
and P. maniculatus TR016 was captured inside a shed frequently visited by the patient,
suggesting that site 1 may be the site of infection rather than site 2, although we did
not ﬁnd that the rodent SNV genomes clustered based on trapping site.
Next, we analyzed speciﬁc amino acid variations within the N, Gn/Gc, and L genes in
two samples from site 1 (TR008 and TR016), one sample from site 2 (T2041), SNV isolate
SN77734 expanded in Vero E6 cells, and the patient samples and compared them to the
published SNV reference sequence (NMH10). We found 21 amino acid polymorphisms,
with 6 of these being conserved across all the samples and an additional 4 being found
only in the cell culture-passaged SN77734 strain (Table 2). The N protein showed two
amino acid variants, whereas more variants were found in the glycoprotein Gn/Gc and
the viral RNA-dependent RNA polymerase. A total of six single-amino-acid changes were
found only in the site 2 virus, whereas four were found only in the site 1 viruses (all of
which were also found in the patient virus), compared to the reference sequence. Further
investigation on whether these variants are relevant for pathogenesis or rodent-to-human
December 2021 Volume 95 Issue 23 e01534-21
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TABLE 2 SNV amino acid variants detected between patient and rodent samples, controls, and the SNV reference sequence
Amino acid
position
89
110
47
85
217
313
504
1120
1140
11
51
242
260
265
276
645
954
1791
1806
1883
1940

Amino acid change
Reference sequence
H
E
I
K
V
E
A
I
N
V
K
N
K
N
S
I
I
R
K
A
R

Sample
D
Q
T
R
I
D
T
V
T
I
E
S
R
S
D
V
T
K
R
T
K

Position in protein
structure
Nucleocapsid
Nucleocapsid
Glycoprotein (Gn)
Glycoprotein (Gn)
Glycoprotein (Gn)
Glycoprotein (Gn)
Glycoprotein (Gn)
Glycoprotein (Gc)
Glycoprotein (Gc)
RNA polymerase
RNA polymerase
RNA polymerase
RNA polymerase
RNA polymerase
RNA polymerase
RNA polymerase
RNA polymerase
RNA polymerase
RNA polymerase
RNA polymerase
RNA polymerase

Sample(s) that contains amino acid
change relative to reference sequence
T2041 (site 2)
T2041 (site 2)
All
T2041 (site 2)
Patient, TR008, TR016 (site 1)
T2041 (site 2)
All
SNV Vero
SNV Vero
SNV Vero
SNV Vero
Patient, TR008/TR016 (site 1)
Patient, TR008/TR016 (site 1)
T2041 (site 2)
All
T2041 (site 2)
All except SNV Vero
All
Patient, TR008/TR016 (site 1)
All
All

transmission is warranted. Additional experiments are required to assess if there are multiple SNV networks circulating in this population or whether this represents a single introduction into the population.
Multiple rodent species as potential reservoirs for SNV. As shown in Table 1, we
discovered SNV in rodents other than the known carrier P. maniculatus, including P.
boylii, M. musculus, and T. minimus. We sequenced SNV from one animal for each of
these rodents and were able to generate a partial genome (50 to 60%) for these samples (TR009, TR057, and T2058). Based on these sequences, we found that the SNV
sequences in these rodents grouped more closely with the other SNV sequences from
this study than with previously reported SNV samples, and these sequences did not
group with previously published non-SNV hantavirus sequences (Fig. 3). Furthermore,
we conﬁrmed this ﬁnding by analyzing individual segment sequences (Fig. 4). These
data provide the ﬁrst evidence that SNV can be harbored by multiple rodent species at
the geographical site of a human SNV infection, suggesting that multiple rodent species may act as hosts for SNV and potentially transmit the virus to humans.
Identifying host reservoirs that contribute to zoonosis for emerging and reemerging
pathogens has implications for human health (26–30). Molecular tools such as RT-qPCR
and viral sequencing can help diagnose and understand these spillover events in
humans by allowing the rapid screening of infected host and human samples while
comparing viral genome sequences. With advances in technology, sequencing has
become essential in tracking transmission and detecting novel variants in several zoonotic viruses (31–35). Spontaneous outbreaks of SNV and its high case-fatality rate raise
concerns that additional host reservoirs may exist that could contribute to increased
infection rates in humans.
Here, we sequenced large portions of SNV genomes in both infected wild-caught
rodents and patient samples. The SNV sequences from the samples that we report
here did not group in the same clade as SNV CC107 (GenBank accession numbers
KT885044, KT885045, and KT885046), which was isolated from P. maniculatus in northern California, suggesting that regional differences exist in SNVs circulating in P. maniculatus populations, as previously shown (36, 37). It has also been shown that partial
sequencing of the S and M segments is sufﬁcient to identify genotypes between SNVs
in P. maniculatus, which generated individual clades for SNVs from mice caught in New
December 2021 Volume 95 Issue 23 e01534-21

jvi.asm.org 6

Sin Nombre Virus Transmission and Rodent Detection

Journal of Virology

FIG 3 Phylogenetic analysis of captured rodents indicates that multiple rodents can be infected with SNV. A
maximum likelihood tree was generated based on S, M, and L segments combined. The numbers below the
branches indicate bootstrap values from 500 replicates. Chipmunk (T. minimus) (purple), common house mouse
(M. musculus) (blue), and pinyon mouse (P. boylii) (orange) genomes from both sites are displayed. The tree
was rooted to the Prospect Hill reference sequence. Additional reference sequences were obtained through the
NCBI and combined. SNV-infected Vero E6 cells (SNV VERO) were used as positive sequencing controls. The bar
represents the number of substitutions per site.

Mexico compared to CC74 (GenBank accession numbers L33816.1, L33684.1, and
L35009.1), another isolate from a P. maniculatus rodent captured in northern California
(37). Previous studies have conducted serum antibody tests to measure SNV prevalence in rodents, with a range from as low as 2% up to 33% depending on the rodent
and study (3, 4, 6, 38). Our results indicate a high rate of SNV prevalence (39%) based
on the detection of SNV genomic RNA in lung tissue from rodents trapped near the
patient’s residence. The use of RT-qPCR rather than serum antibody tests may be more
sensitive and less prone to false-positive results, which can occur from cross-reactive
antibodies induced by infection with other hantaviruses known to circulate in rodents.
One limitation of our study is the incomplete genome coverage (47 to 99%) from
the SNV tissue samples. Sequencing of SNV expanded in tissue culture results in muchimproved genome coverage; however, in vitro culture can introduce mutations to SNV
that can affect pathogenesis (39). We found that a higher cycle threshold (CT) value
(greater than ;35) resulted in lower genome coverage (24, 40). Future experiments
will focus on the optimization of the SNV sequencing protocol from wild-caught
rodent tissue samples.
Our ﬁndings are the ﬁrst to report the sequencing of large portions of SNV in rodents
other than P. maniculatus. This is notable since the primary host of SNV is thought to be
P. maniculatus, but an understanding of the barriers that restrict orthohantavirus spillover into additional host populations remains elusive. Antibody-based tests can help
monitor and survey SNV prevalence in populations of small mammals, including P. maniculatus (3, 5, 37, 41–43). However, to date, only a few studies have reported serum antibodies against SNV in the genus Tamias (chipmunk) (3, 4, 41), and few reports of detection of SNV genomes by speciﬁc RT-qPCR have been demonstrated (6). Furthermore, no
genome sequencing of SNV in non-P. maniculatus species has been reported. Given the
cross-reactivity of serum antibodies against multiple hantaviruses and the widespread
distribution of avirulent hantaviruses in rodent populations, sequencing is vital to conﬁrm SNV infection in rodents (3, 4, 6). The grouping of SNV samples from multiple
December 2021 Volume 95 Issue 23 e01534-21

jvi.asm.org 7

Goodfellow et al.

Journal of Virology

FIG 4 Phylogenetic analysis of individual segments. A maximum likelihood tree was generated based on S, M, and L segments individually. The numbers
below the branches indicate bootstrap values from 500 replicates. Rodents from site 1 (orange) and site 2 (blue) are labeled accordingly, along with
patient samples (teal). The tree was rooted to the Prospect Hill reference sequence. Additional reference sequences were obtained through the NCBI. SNVinfected Vero E6 cells (SNV VERO) were used as positive sequencing controls. The bars represent the number of substitutions per site.

rodents such as P. boylii, M. musculus, and T. minimus with SNV samples from P. maniculatus raises concerns that additional rodent reservoirs can potentially cause zoonoses. It
is unknown whether these represent spillover events from P. maniculatus to other
rodents and are dead-end hosts or if these rodents are reservoirs for SNV. Interestingly,
the overlap of rodent populations due to their distribution in this study may contribute
to this phenomenon of spillover. It has been shown that multiple Peromyscus species reside in New Mexico along with T. minimus in the northern parts of the state, which may
contribute to higher competition for resources and interactions between different small
mammals allowing increased spillover of SNV (44, 45). There are reports of Peromyscus
species that can travel over 8 miles from original trap sites (46). Factors such as geographical barriers, resources, and population density can affect rodent dispersal and
migration. Possibly, the SNV spillover is due to multiple conditions that affect the overlap
of rodent habitats. A critical next step is to assess whether any of these rodents can
transmit SNV and whether the SNVs from these rodents are virulent in humans. Multiple
studies have analyzed SNV RNA in feces, urine, or saliva/oropharyngeal ﬂuid in laboratory-infected or naturally infected P. maniculatus. In general, SNV-infected animals had
undetectable viral RNA in feces and a low prevalence in urine but a potentially higher
frequency in saliva or oropharyngeal ﬂuid (47–50). Future work should address whether
SNV is found at a higher level in the excreta of P. maniculatus than in other infected
rodents. Additional surveying and sequencing will help to further understand the role of
these hosts in hantavirus ecology and transmission.
In conclusion, we report a case study for an SNV-infected patient, followed by
rodent capture and the use of molecular tools and viral genome sequencing technology to trace transmission to a potential site and activity (cleaning of the shed at site 1).
While doing so, we also discovered that multiple rodents, including T. minimus, P. boylii, and M. musculus, can be infected with SNV (Fig. 5).
December 2021 Volume 95 Issue 23 e01534-21
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FIG 5 Tracing SNV infection in both the patient and rodents. Patient samples were conﬁrmed for SNV
infection, and wild-caught rodents caught at two potential sites of infection were tested for SNV. A whole viral
genome sequencing approach was used on patient and rodent samples to determine site 1 as a possible
source of SNV patient exposure. This study reports for the ﬁrst time the use of whole viral genome sequencing
to study SNV epidemiology.

MATERIALS AND METHODS
Plasmid construction, cultured virus, and clinical samples. A plasmid carrying Sin Nombre virus N
was generated by GenScript using the N gene from the S segment sequence in a pFastBac1 backbone
and was used for the RT-qPCR standard curve. For positive virus controls, Vero E6 cells were infected
with Sin Nombre virus (SN77734) at a multiplicity of infection (MOI) of 1 in a biosafety level 3 (BSL-3) facility, and RNA was extracted after lysis. Patient serum, whole blood, and plasma were obtained after
patient consent in accordance with institutional review board (IRB) protocol 17-382. SNV infection was
conﬁrmed by RT-qPCR using primers and a probe that were adopted from previously published sets
based on the detection of the S segment of the Sin Nombre virus genome (18). Human ACTB (beta-actin)
primers with a VIC/TAMRA (6-carboxytetramethylrhodamine) dye probe (catalog number 4310881E;
Applied Biosystems) were used as endogenous positive controls.
Rodent sample collection. A total of 69 rodents were collected over 2 consecutive nights (160 trap
nights), which included two sites in northern New Mexico, with permission of the property owner.
Sherman live traps (3 by 3.5 by 9 in.; H. B. Sherman Co., Tallahassee, FL) baited with peanut butter and
oats were used. All ﬁeld procedures were performed according to the animal care and use guidelines of
the American Society of Mammalogists (54, 55) and approved by the University of New Mexico
Institutional Animal Care and Use Committee, and animals were collected under a New Mexico
Department of Game and Fish permit (authorization number 3300). Holistic museum specimens were
prepared according to best practices for emerging pathogen research and databased in a relational collection management system (https://arctosdb.org) to facilitate linkage of host specimen data and
derived pathogen data (51, 52). Measurements (total length, tail length, hind foot [with claw], ear [from
notch], and weight), reproductive data (sex, reproductive status, and testes and embryo crown-rump
measurements), and age were recorded. Species identiﬁcations were determined through a combination
of measurement data and morphological characteristics and conﬁrmed by cytochrome b sequence analysis. Collected tissues were snap-frozen in liquid nitrogen and included brown fat, spleen, heart, lung,
kidney, liver, colon (with feces), urinary bladder (with urine if present), and serum from blood centrifuged in the ﬁeld. Animal specimens were deposited in the University of New Mexico, Museum of
Southwestern Biology (MSB) with catalog numbers MSB:Mamm:332811 to -332874, -332702, -332703,
-332706, -332711, and -332767.
RNA extraction. RNA extraction of rodent lung tissue was performed using the QIAamp viral RNA
minikit (Qiagen) according to the manufacturer’s instructions, with slight modiﬁcations. Brieﬂy, an average of 40 mg of frozen lung tissue was added to a bead beater tube preloaded with 1.0 g of 1.0-mm-diameter zirconia beads (catalog number 1107911zx; BioSpec), 1.0 g of 2.0-mm-diameter zirconia beads
(catalog number 11079124zx; BioSpec), and 800 m l of AVL buffer. The tissue was bead beaten using a
Benchmark Bead Bug-6 instrument at a speed of 4,350 rpm for 30 s for 1 cycle. Homogenates were centrifuged, pipetted into a microcentrifuge vial, and centrifuged to remove debris, and the clear lysate was
pipetted into a fresh microcentrifuge vial. The RNA carrier was then added to the clear lysate, and RNA
extraction proceeded according to the manufacturer’s instructions.
Reverse transcriptase quantitative PCR. Two-step reverse transcription (RT) using SuperScript II
(Invitrogen, Thermo Fisher Scientiﬁc) was established for the QuantStudio5 series system (Applied
Biosystems). RT was performed using 5 m l of RNA (;500 ng) with 1 m l of SuperScript II containing 4 m l
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5 ﬁrst strand buffer, 2 m l 0.1 M dithiothreitol (DTT), 1 m l RNaseOUT, 1 m l random primers, 1 m l deoxynucleoside triphosphate (dNTP) mix (10 mM), and 5 m l of reverse transcriptase quantitative PCR (RT-qPCR)grade water. This reaction mixture was incubated at 65°C for 5 min and placed on ice brieﬂy, followed
by 10 min at room temperature for binding with a 50-min reaction at 42°C, which was then terminated
by 15 min at 70°C. RT-qPCRs were carried out by using 10 m l TaqMan Fast advanced master mix (catalog
number 4444965; Applied Biosystems, Thermo Fisher Scientiﬁc) containing 2 m l cDNA (;200 ng), 2 m l
primer (2.5 m M), 1 m l of either probe (10 m M), and 4 to 5 m l diethyl pyrocarbonate (DEPC)-treated water
(Nalgene) in a 20-m l ﬁnal reaction volume. For each sample, duplicate or triplicate wells were tested
using the following cycling conditions: 20 s at 95°C for the hold stage, while the PCR stage used 1 s at
95°C followed by 52°C for 20 s for a total of 40 cycles. Controls included a no-template control (NTC), a
positive SNV sample, a plasmid used for the standard curve, and positive and negative patient samples
or wild-caught rodent samples. Additionally, b -actin primers (forward [F] primer ATG TAC GTA GCC ATC
CAG GC and reverse [R] primer TCT TGC TCG AAG TCT AGG GC) speciﬁc for P. maniculatus or human
ACTB were used as internal controls (53). QuantStudio Design and Analysis software v1.5.1 and
GraphPad Prism v9.0.2 were used for analysis and graphs.
Whole-genome sequencing of Sin Nombre virus. Genome sequencing of SNV was conducted on
cDNA of RNA isolated from clinical samples and tissues obtained from wild-caught rodents that tested
positive by RT-qPCR. SNV genomes were ampliﬁed using a PCR-tiling approach with the generation of
primer pools designed using PrimalScheme (https://primalscheme.com/) (24) against SNV genomes
available through the National Center for Biotechnology Information (NCBI). The primers are listed in
Table S1 in the supplemental material. Primers were tested using GoTaq green master mix (catalog number M7123; Promega) and SNV-infected Vero E6 cells with an adjusted annealing temperature of 62°C
for 40 cycles. DNA gel electrophoresis was then performed using 2% agarose gels run at 80 V (120 V
depending on the size of the gel) with a 100-bp DNA ladder and imaged using an Analytik Jena gel
imager. Using a slightly modiﬁed version of a SARS-CoV-2 genome sequencing protocol (https://github
.com/CDCgov/SARS-CoV-2_Sequencing/blob/master/protocols/ONT-COVID-19_Tiling/PCR%20tiling%20of%
20COVID-19%20virus-minion.pdf), samples were sequenced using an Oxford Nanopore GridION X5 system,
with gaps partially ﬁlled by Sanger sequencing (Sequetech).
Bioinformatics, phylogenetic analysis, and additional software used. FASTQ ﬁles were concatenated and adapters were trimmed using TrimGalore v0.6.1 (https://www.bioinformatics.babraham.ac.uk/
projects/trim_galore/). Using the artic-ncov2019 pipeline (https://artic.network/ncov-2019/ncov2019
-bioinformatics-sop.html), FASTQ ﬁles were processed for individual segments and then combined to
generate a full consensus genome. Consensus bases were called at a minimum threshold of a 10 depth
of coverage, and the consensus genomes were viewed through SnapGene v5.2. SNV genomes were
aligned with CLUSTAL Omega and Jalview. Molecular Evolutionary Genetics Analysis (MEGA-X) was used
to construct a maximum likelihood tree with 500 bootstraps. Phylogenetic tree ﬁgures were generated
using Interactive Tree of Life (iTOL). CLUSTAL Omega was also used to produce percent identity matrices. Reference sequences (GenBank accession numbers) used in the analysis are as follows: Sin Nombre
NMR11 (L37902 to L37904.1), Sin Nombre NMH10 (NC_005215 to NC_005217.1), Sin Nombre (P. maniculatus) (KF537001 to KF537003.1), Sin Nombre Vero E6 (KF537004 to KF537006.1), Convict Creek 74
(L33816.1, L33684.1, and L35009.1), Convict Creek 107 (KT885044 to KT885046.1), Prospect Hill (NC
_038938 to NC_038940.1), Cano Delgadito (NC_034528.1, NC_034525.1, and NC_034515.1), Andes (NC
_003466 to NC_003468.1), Choclo (NC_038373 to NC_038374.1), Bayou (NC_038298 to NC_038300.1),
Muleshoe (KX066124 to KX066125.1), Black Creek Canal (NC_043073 to NC_043075.1), New York
(MG717391 to MG717393.1), El Moro Canyon (NC_038423 to NC_038424.1), and Limestone Canyon
(AF307322 to AF307323.1). ExPASy was used to convert nucleotides into amino acids to view variants.
Figure 5 was created with BioRender.
Data availability. Sequences have been deposited in GenBank (accession numbers MZ787939 to
MZ787941, MZ787943 to MZ787945, and MZ851449 to MZ851475).
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